Hims & Hers Health (HIMS) Receivables (2020 - 2026)

Hims & Hers Health (HIMS) has 7 years of Receivables data on file, last reported at $149.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $149.6 million; the trailing twelve-month figure through Mar 2026 stood at $149.6 million (changed N/A YoY), and the FY2025 full-year result was $32.1 million, up 427.03% from the prior year.
• Receivables improved to $149.6 million in Q1 2026, from $32.1 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $149.6 million in Q1 2026 to a low of $3.9 million in Q4 2022.
• A 5-year average of $39.7 million and a median of $6.7 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables retreated 8.96% in 2024 and surged 427.03% in 2025, its largest moves.
• Tracing HIMS's Receivables over 5 years: stood at $3.9 million in 2022, then surged by 71.79% to $6.7 million in 2023, then dropped by 8.96% to $6.1 million in 2024, then surged by 427.03% to $32.1 million in 2025, then soared by 365.4% to $149.6 million in 2026.
• Business Quant data shows HIMS's Receivables at $149.6 million in Q1 2026, $32.1 million in Q4 2025, and $6.1 million in Q4 2024.